AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
HUMAN AND MURINE ANTIBODY RECOGNITION IS FOCUSED ON THE ATPASE HELICASE, BUT NOT THE PROTEASE DOMAIN OF THE HEPATITIS-C VIRUS NONSTRUCTURAL-3 PROTEIN/
Authors: CHEN M SALLBERG M SONNERBORG A JIN L BIRKETT A PETERSON D WEILAND O MILICH DR
Citation: M. Chen et al., HUMAN AND MURINE ANTIBODY RECOGNITION IS FOCUSED ON THE ATPASE HELICASE, BUT NOT THE PROTEASE DOMAIN OF THE HEPATITIS-C VIRUS NONSTRUCTURAL-3 PROTEIN/, Hepatology, 28(1), 1998, pp. 219-224
VARIATION IN THE HEPATITIS-C VIRUS NS5A REGION IN RELATION TO HYPERVARIABLE REGION-1 HETEROGENEITY DURING INTERFERON TREATMENT
Authors: ODEBERG J YUN ZB SONNERBORG A WEILAND O LUNDEBERG J
Citation: J. Odeberg et al., VARIATION IN THE HEPATITIS-C VIRUS NS5A REGION IN RELATION TO HYPERVARIABLE REGION-1 HETEROGENEITY DURING INTERFERON TREATMENT, Journal of medical virology, 56(1), 1998, pp. 33-38
GBV-C HGV INFECTION IN HEPATITIS-C VIRUS-INFECTED DEFERRED SWEDISH BLOOD-DONORS/
Authors: SHEV S BJORKMAN P NORKRANS G FOBERG U FRYDEN A LINDH G LINDHOLM A WEILAND O WIDELL A
Citation: S. Shev et al., GBV-C HGV INFECTION IN HEPATITIS-C VIRUS-INFECTED DEFERRED SWEDISH BLOOD-DONORS/, Journal of medical virology, 54(2), 1998, pp. 75-79
CAN HCV INFECTION BE CLEARED (VOL 352, PG 669, 1998)
Authors: WEILAND O
Citation: O. Weiland, CAN HCV INFECTION BE CLEARED (VOL 352, PG 669, 1998), Lancet, 352(9134), 1998, pp. 1154-1154
CAN HCV INFECTION BE CLEARED
Authors: WEILAND O
Citation: O. Weiland, CAN HCV INFECTION BE CLEARED, Lancet, 352(9129), 1998, pp. 669-670
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INTERFERON-ALPHA-2B WITH AND WITHOUT RIBAVIRIN FOR CHRONIC HEPATITIS-C
Authors: REICHARD O NORKRANS G FRYDEN A BRACONIER JH SONNERBORG A WEILAND O
Citation: O. Reichard et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INTERFERON-ALPHA-2B WITH AND WITHOUT RIBAVIRIN FOR CHRONIC HEPATITIS-C, Lancet, 351(9096), 1998, pp. 83-87
BENGTSSON,STELLAN IN-MEMORIAM
Authors: BRACONIER JH NILSSONEHLE I NORRBY R WEILAND O
Citation: Jh. Braconier et al., BENGTSSON,STELLAN IN-MEMORIAM, Scandinavian journal of infectious diseases, 30(1), 1998, pp. 3-3
THE ANTIVIRAL COMPOUND RIBAVIRIN MODULATES THE T-HELPER (TH)1 TH2 SUBSET BALANCE IN HEPATITIS-B AND HEPATITIS-C VIRUS-SPECIFIC IMMUNE-RESPONSES/
Authors: HULTGREN C MILICH DR WEILAND O SALLBERG M
Citation: C. Hultgren et al., THE ANTIVIRAL COMPOUND RIBAVIRIN MODULATES THE T-HELPER (TH)1 TH2 SUBSET BALANCE IN HEPATITIS-B AND HEPATITIS-C VIRUS-SPECIFIC IMMUNE-RESPONSES/, Journal of General Virology, 79, 1998, pp. 2381-2391
GENOTYPING OF HEPATITIS-C VIRUS PERFORMED BY TYPE-SPECIFIC PCR IN COMPARISON TO NUCLEOTIDE SEQUENCING OF NS5 AND CORE REGIONS
Authors: YUN Z JOHANSSON B WEILAND O SONNERBORG A
Citation: Z. Yun et al., GENOTYPING OF HEPATITIS-C VIRUS PERFORMED BY TYPE-SPECIFIC PCR IN COMPARISON TO NUCLEOTIDE SEQUENCING OF NS5 AND CORE REGIONS, Research in virology, 148(3), 1997, pp. 233-237
THERAPY OF HEPATITIS-C - ALPHA-INTERFERON AND RIBAVIRIN
Authors: REICHARD O SCHVARCZ R WEILAND O
Citation: O. Reichard et al., THERAPY OF HEPATITIS-C - ALPHA-INTERFERON AND RIBAVIRIN, Hepatology, 26(3), 1997, pp. 108-111
RIBAVIRIN ENHANCES THE EFFICACY BUT NOT THE ADVERSE-EFFECTS OF INTERFERON IN CHRONIC HEPATITIS-C - METAANALYSIS OF INDIVIDUAL PATIENT DATA FROM EUROPEAN CENTERS
Authors: SCHALM SW HANSEN BE CHEMELLO L BELLOBUONO A BROUWER JT WEILAND O CAVALLETTO L SCHVARCZ R IDEO G ALBERTI A
Citation: Sw. Schalm et al., RIBAVIRIN ENHANCES THE EFFICACY BUT NOT THE ADVERSE-EFFECTS OF INTERFERON IN CHRONIC HEPATITIS-C - METAANALYSIS OF INDIVIDUAL PATIENT DATA FROM EUROPEAN CENTERS, Journal of hepatology, 26(5), 1997, pp. 961-966
INTERFERON-ALPHA TREATMENT INDUCES DELAYED CD4 PROLIFERATIVE RESPONSES TO THE HEPATITIS-C-VIRUS NONSTRUCTURAL PROTEIN-3 REGARDLESS OF THE OUTCOME OF THERAPY
Authors: ZHANG ZX MILICH DR PETERSON DL BIRKETT A SCHVARCZ R WEILAND O SALLBERG M
Citation: Zx. Zhang et al., INTERFERON-ALPHA TREATMENT INDUCES DELAYED CD4 PROLIFERATIVE RESPONSES TO THE HEPATITIS-C-VIRUS NONSTRUCTURAL PROTEIN-3 REGARDLESS OF THE OUTCOME OF THERAPY, The Journal of infectious diseases, 175(6), 1997, pp. 1294-1301
UTILITY OF AN ANONYMOUS QUESTIONNAIRE FOR THE IDENTIFICATION OF A PRIMARY TRANSMISSION ROUTE AND POSSIBLE SECONDARY TRANSMISSION IN ADULTS WITH ACUTE HEPATITIS-B VIRUS-INFECTION
Authors: STRUVE J GIESECKE J LINDH G WEILAND O
Citation: J. Struve et al., UTILITY OF AN ANONYMOUS QUESTIONNAIRE FOR THE IDENTIFICATION OF A PRIMARY TRANSMISSION ROUTE AND POSSIBLE SECONDARY TRANSMISSION IN ADULTS WITH ACUTE HEPATITIS-B VIRUS-INFECTION, European journal of epidemiology, 12(3), 1996, pp. 319-322
INTERFERON-ALPHA AND RIBAVIRIN VERSUS INTERFERON-ALPHA ALONE AS THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Authors: REICHARD O NORKRANS G FRYDEN A BRACONIER JH ALAEUS A GLAUMANN H SCHVARCZ R SONNERBORG A WEJSTAL R WEILAND O
Citation: O. Reichard et al., INTERFERON-ALPHA AND RIBAVIRIN VERSUS INTERFERON-ALPHA ALONE AS THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Hepatology, 24(4), 1996, pp. 917-917
RIBAVIRIN TREATMENT FOR PATIENTS WITH CHRONIC HEPATITIS-C - RESULTS OF A PLACEBO-CONTROLLED STUDY
Authors: DUSHEIKO G MAIN J THOMAS H REICHARD O LEE C DHILLON A RASSAM S FRYDEN A REESINK H BASSENDINE M NORKRANS G CUYPERS T LELIE N TELFER P WATSON J WEEGINK C SILLIKENS P WEILAND O
Citation: G. Dusheiko et al., RIBAVIRIN TREATMENT FOR PATIENTS WITH CHRONIC HEPATITIS-C - RESULTS OF A PLACEBO-CONTROLLED STUDY, Journal of hepatology, 25(5), 1996, pp. 591-598
INTERFERON-RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS-C
Authors: SCHALM SW BROUWER JT CHEMELLO L ALBERTI A BELLOBUONO A IDEO G SCHWARTZ R WEILAND O
Citation: Sw. Schalm et al., INTERFERON-RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS-C, Digestive diseases and sciences, 41(12), 1996, pp. 131-134
RESTRICTION OF HEPATITIS-C VIRUS HETEROGENEITY DURING PROLONGED INTERFERON-ALPHA THERAPY IN RELATION TO CHANGES IN VIRUS LOAD
Authors: YUN ZB ODEBERG J LUNDEBERG J WEILAND O UHLEN M SONNERBORG A
Citation: Zb. Yun et al., RESTRICTION OF HEPATITIS-C VIRUS HETEROGENEITY DURING PROLONGED INTERFERON-ALPHA THERAPY IN RELATION TO CHANGES IN VIRUS LOAD, The Journal of infectious diseases, 173(4), 1996, pp. 992-996
HCV GENOTYPES IN SWEDISH BLOOD-DONORS AS CORRELATED TO EPIDEMIOLOGY, LIVER-DISEASE AND HEPATITIS-C VIRUS-ANTIBODY PROFILE
Authors: SHEV S WIDELL A FOBERG U FRYDEN A HERMODSSON S LINDH G LINDHOLM A MANSSON S WEILAND O NORKRANS G
Citation: S. Shev et al., HCV GENOTYPES IN SWEDISH BLOOD-DONORS AS CORRELATED TO EPIDEMIOLOGY, LIVER-DISEASE AND HEPATITIS-C VIRUS-ANTIBODY PROFILE, Infection, 23(5), 1995, pp. 253-257
RESPONSE TO A BOOSTER DOSE 18 MONTHS AFTER A LOW ANTI-HBS RESPONSE (10-99 IU I) TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTEREDRECOMBINANT HEPATITIS-B VACCINE/
Authors: STRUVE J ARONSSON B FRENNING B FORSGREN M WEILAND O
Citation: J. Struve et al., RESPONSE TO A BOOSTER DOSE 18 MONTHS AFTER A LOW ANTI-HBS RESPONSE (10-99 IU I) TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTEREDRECOMBINANT HEPATITIS-B VACCINE/, Infection, 23(1), 1995, pp. 42-45
2-YEAR BIOCHEMICAL, VIROLOGICAL, AND HISTOLOGICAL FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS-C RESPONDING IN A SUSTAINED FASHION TO INTERFERON ALFA-2B TREATMENT
Authors: REICHARD O GLAUMANN H FRYDEN A NORKRANS G SCHVARCZ R SONNERBORG A YUN ZB WEILAND O
Citation: O. Reichard et al., 2-YEAR BIOCHEMICAL, VIROLOGICAL, AND HISTOLOGICAL FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS-C RESPONDING IN A SUSTAINED FASHION TO INTERFERON ALFA-2B TREATMENT, Hepatology, 21(4), 1995, pp. 918-922
COMBINATION TREATMENT WITH INTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS-C IN PATIENTS WHO HAVE FAILED TO ACHIEVE SUSTAINED RESPONSE TO INTERFERON ALONE - SWEDISH EXPERIENCE
Authors: SCHVARCZ R ANDO Y SONNERBORG A WEILAND O
Citation: R. Schvarcz et al., COMBINATION TREATMENT WITH INTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS-C IN PATIENTS WHO HAVE FAILED TO ACHIEVE SUSTAINED RESPONSE TO INTERFERON ALONE - SWEDISH EXPERIENCE, Journal of hepatology, 23, 1995, pp. 17-21
PANEL DISCUSSION
Authors: SHERLOCK S MAIN J TREPO C WEILAND O BRILLANTI S ALBERTI A
Citation: S. Sherlock et al., PANEL DISCUSSION, Journal of hepatology, 23, 1995, pp. 37-40
RISK-FACTORS FOR HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTION AMONG SWEDISH EXPATRIATES
Authors: STRUVE J NORRBOHM O STENBECK J GIESECKE J WEILAND O
Citation: J. Struve et al., RISK-FACTORS FOR HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTION AMONG SWEDISH EXPATRIATES, The Journal of infection, 31(3), 1995, pp. 205-209
COMBINED TREATMENT WITH INTERFERON-ALPHA-2B AND RIBAVIRIN FOR CHRONICHEPATITIS-C IN PATIENTS WITH A PREVIOUS NONRESPONSE OR NONSUSTAINED RESPONSE TO INTERFERON ALONE
Authors: SCHVARCZ R YUN ZB SONNERBORG A WEILAND O
Citation: R. Schvarcz et al., COMBINED TREATMENT WITH INTERFERON-ALPHA-2B AND RIBAVIRIN FOR CHRONICHEPATITIS-C IN PATIENTS WITH A PREVIOUS NONRESPONSE OR NONSUSTAINED RESPONSE TO INTERFERON ALONE, Journal of medical virology, 46(1), 1995, pp. 43-47
HEPATITIS-E VIRUS-INFECTIONS IN PATIENTS WITH ACUTE HEPATITIS NON-A-DIN SWEDEN
Authors: JOHANSSON PJH MUSHAHWAR IK NORKRANS G WEILAND O NORDENFELT E
Citation: Pjh. Johansson et al., HEPATITIS-E VIRUS-INFECTIONS IN PATIENTS WITH ACUTE HEPATITIS NON-A-DIN SWEDEN, Scandinavian journal of infectious diseases, 27(6), 1995, pp. 543-546
Risultati: 1-25 | 26-45